Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
4/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81 · book equity (no price)
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $5M buybacks = $5M returned on -$14M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 2 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -2063%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 2 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~26.3% on $2M of debt.
Cash of $865624 is below short-term debt of $2M — relies on refinancing/operations.
Mostly short-term debt (balance-sheet current vs non-current split). A year-by-year maturity schedule wasn't disclosed for this issuer.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 |
|---|---|---|
| Revenue | $5.8M 100.0% | $173K 100.0% |
| Cost of Revenue | $3.1M 54.0% | $44K 25.3% |
| Gross Profit | $2.7M 46.0% | $129K 74.7% |
| Research & Development | $1.4M 24.9% | $850K 492.4% |
| Selling, General & Admin | $6.8M 116.5% | $1.6M 905.4% |
| Total Operating Expenses | $13.1M 225.2% | $7.2M 4154.8% |
| Operating Income | -$10.4M -179.2% | -$7.0M -4080.1% |
| Interest Expense | $405K 7.0% | — |
| Other Income (Expense), net | -$26.3M -453.4% | -$14.5M -8393.4% |
| Pretax Income | -$36.7M -632.6% | -$21.5M -12473.5% |
| Income Tax Expense | — | $581 0.3% |
| Net Income | -$36.7M -632.6% | -$21.5M -12473.8% |
| Per Share | ||
| EPS (Basic) | $-1.78 | $-1.78 |
| EPS (Diluted) | $-1.78 | $-1.78 |
| Weighted Avg Shares (Basic) | 20.6M | 12.1M |
| Weighted Avg Shares (Diluted) | 20.6M | 12.1M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
No current price collected.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Low operating leverage — profit tracks sales closely (stable, less cyclical).
Each line as % of revenue — the trend in color
| % of revenue | FY2024 | FY2025 |
|---|---|---|
| Cost of Revenue | 25.3 | 54.0 |
| Gross Profit | 74.7 | 46.0 |
| R&D | 492.4 | 24.9 |
| SG&A | 905.4 | 116.5 |
| Operating Income | -4080.1 | -179.2 |
| Income Tax | 0.3 | — |
| Net Income | -12473.8 | -632.6 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on DAIC: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
No trend data available for this metric.
Top 30 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.